Innovations in Trauma - 140 Pages

  1. P. 1

  2. P. 2

  3. P. 3

  4. P. 4

  5. P. 5

  6. P. 6

  7. P. 7

  8. P. 8

  9. P. 9

  10. P. 10

  11. P. 20

  12. P. 30

  13. P. 40

  14. P. 50

  15. P. 60

  16. P. 70

  17. P. 80

  18. P. 90

  19. P. 100

Catalogue excerpts

Annual Report 2015 Innovations in Trauma

 Open the catalogue to page 1

Selected Figures Sales and Result Sales EBITDA EBIT Net result Cash flow and Investments Operative Cash flow Investing activities in intangible assets Investing activities in tangible assets Total investing activities Value Development Intangible asstes Tangible assets Working capital Non-current assets Current assets Capital Structure Total assets Shareholders‘ equity Equity ratio Closing price 12/31 (EUR/Share) Market capitalization 12/31 (million pieces) Average price (EUR/Share) High (EUR/Share) Low (EUR/Share) Ø Daily turnover (KEUR) Employees Employees (Headcount) Employees (FTE) Share****...

 Open the catalogue to page 2

Annual Report 2015 Innovations in Trauma

 Open the catalogue to page 3

aap Implantate AG | Annual Report 2015

 Open the catalogue to page 4

Company Information • Foreword by the Management Board • Supervisory Board Report • LOQTEQ® Roadmap. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 • Corporate Governance Report and Statement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 • The Share. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....

 Open the catalogue to page 5

aap Implantate AG | Annual Report 2015

 Open the catalogue to page 6

Company Information Annual Report 2015 | aap Implantate AG

 Open the catalogue to page 7

Company Information Foreword by Ladies and Gentlemen, the Management Dear Shareholders, Employees, Board and Business Partners, Bruke Seyoum Alemu Chairman of the Management Board / CEO Marek Hahn Member of the Management Board / CFO In 2015 we made significant progress in implementing our strategy, and achieved many of the targets that had been set. However, the financial year 2015 was also a very challenging year for aap. We further expanded our LOQTEQ® portfolio in financial year 2015, and are now able to provide treatment for over 90% of indications for major bones fractures. This has significantly...

 Open the catalogue to page 8

Company Information With regard to the outlook for the upcoming financial year and beyond, we are convinced that the sales activities described and our current and upcoming innovation speed will allow the growth story in the trauma segment to remain intact, and that we will be able to achieve a 5-year CAGR of 20%. As a pure player in trauma, we will be in a position to make even better use of the opportunities in the fast growing global trauma market with a focused business model. In this respect, our three IP-protected platform technologies, LOQTEQ®, silver coating and magnesium, offer considerable...

 Open the catalogue to page 9

Company Information Supervisory Supervision and Advice by Means of Regular Board Report Exchanges with the Management Board The Supervisory Board performed in the reporting year the tasks with great care that are incumbent on by law and by the company’s articles of association and rules of procedure. It advised the Management Board on the running of the company, monitoring its activities regularly and ensuring that everything was legal, orderly and fit for purpose. The Management Board fulfilled its obligation to inform the Supervisory Board and kept it informed regularly, comprehensively and...

 Open the catalogue to page 10

Company Information tegic trends and with the Group’s further de- the valuation of receivables and the reporting velopment. according to IFRS 5. The Supervisory Board was supplied with copies of the annual finanCorporate Governance cial statements and management report, the During the financial year the Supervisory Board consolidated financial statements and group maintained a watching brief on the implementa- management report and the auditor’s reports. tion of the provisions of the German Corporate They were discussed in detail at the Supervisory Governance Code and the development of Cor- Board’s...

 Open the catalogue to page 11

Company Information Roadmap With the aim of becoming a leading European trauma company, aap offers its customers solutions for better and more cost-effective treatment of trauma fractures. aap’s platform technologies address previously unmet needs in the health care system and therefore provide continuous value creation and sustainable growth. The following section provides an overview of the existing product and technology portfolio, as well as the company’s innovative development projects that will be made ready for the market in the future. Anatomical Plating System procedures focus • IP-protected...

 Open the catalogue to page 12

Company Information Our Innovation Pipeline resorbable antibacterial • IP-protected technology • Coated magnesium implants • IP-protected technology • Bioabsorbable with controlled degradation • Highly stable silver coating • Avoid second intervention • Excellent biocompatibility • High antibacterial efficacy aap aims to maintain or improve the patient’s mobility and, as such, to guarantee a crucial element of their quality of life. Restoring painless mobility in everyday life, in sport and leisure activities also in old age, combined with short recovery times from as few as possible invasive...

 Open the catalogue to page 13

Company Information market launch, aap has gradually expanded its range of offered anatomical plating systems. With the expanded portfolio, the new FDA and LOQTEQ® - The concept CE approvals, and the positive sales trend, LOThe concept of the LOQTEQ® technology is QTEQ® is very well received by many customers based on a patented technology featuring a and leading surgeons worldwide. screw-hole geometry, which allows a fracture to be compressed and set at a stable angle in one step using a single screw. The advantage of this technology is the possibility for the surgeon to omit a stage of the operation...

 Open the catalogue to page 14

Company Information Products under the name LOQTEQ® VA represent an extension to the previous LOQTEQ® systems. These are polyaxial implants (VA – Variable Angle), which enable screws to be set at various angles. The plates are fitted with special holes that allow a free choice of angles of up to 15° with subsequent angle-stable locking of the screws. These polyaxial plates are needed to treat regions, such as the hand, where an operation needs to not only provide a high degree of stability, but also flexibility when setting the screws. The system was developed to treat fractures of the distal...

 Open the catalogue to page 15

All Aap Implantate catalogues and technical brochures

  1. Interim repor

    28 Pages

    En